Please join us for the first annual research conference to showcase the people, companies, and key thought leaders working with the endocannabinoid system and medical concepts for the use of cannabinoid therapeutics in neurological disorders. Opening dinner reception will be held on Sunday, April 10th followed by a full-day conference on Monday, April 11th in Boston.

With over 27 US states and several countries now legalizing medicinal use of cannabis, the endocannabinoid system is becoming an important public health topic and a rich area of discovery for novel therapeutic interventions. With the recent advent of next generation sequencing and the enablement of personalized medicine, never before in history have we been as well-positioned to better understand the genetics and regulation of the endocannabinoid system. Likewise, the intersection of mobile analytical technologies is enabling a new field of safety testing for production of cannabinoids. CannMed 2016: Personalized Cannabinoid Medicine Conference will focus on the intersection of these three powerful fields: cannabinoid-based therapies, personalized medicine, and mobile technologies.

CANNMED WELCOMES
Medical Professionals and Research Scientists studying the Involvement of Endocannabinoid Pathways or the Application of Cannabinoid Therapeutics in the Following Disease Areas:

• Epilepsy and Developmental Disorders
• Chronic and Neuropathic Pain
• Traumatic Brain Injury and Stroke
• Alzheimer’s Disease
• Parkinson’s Disease
• PTSD and Psychiatric Disorders

Who Should Attend:

• Neurology Specialists
• Pain Specialists
• Psychiatric and Developmental Delay Specialists
• Academic and Medical Research Scientists
• Functional and Naturopathic Specialists
• Pharma Professionals
• Medical Cannabis Safety and Genetics Specialists

CONFERENCE TOPICS

• Applications of Cannabinoid Therapeutics in Neurological Disorders
• The Endocannabinoid System and its Involvement in Disease Processes